• Cantor Fitzgerald Reiterates "Neutral" Rating for CRISPR Therapeutics (NASDAQ:CRSP)

    المصدر: Buzz FX / 19 فبراير 2025 11:02:12   America/New_York


    Cantor Fitzgerald Reiterates "Neutral" Rating for CRISPR Therapeutics (NASDAQ:CRSP) Written by MarketBeat February 19, 2025 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) 's stock had its "neutral" rat
    Read more...
شارك على،